FDA Approves OXYCODONE HYDROCHLORIDE — KVK-TECH,INC
KVK-TECH, INC. has received FDA approval for the Abbreviated New Drug Application (ANDA091393) regarding Oxycodone Hydrochloride, a generic formulation competing with the branded opioid name. This market approval is anticipated to intensify price competition for the medication amidst ongoing scrutiny of the generic painkiller market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed